http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2559fa23684ca8c368ab96f22c3e3b86
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Calvert Hilary Calvert |
| name | A. Hilary Calvert A Hilary Calvert |
| given-name | A Hilary A. Hilary A. |
| organization-name | Cancer Research Unit and Department of Chemistry, University of Newcastle, Newcastle upon Tyne, NE2 4HH U.K., AstraZeneca Pharmaceuticals, Alderley Park, Cheshire, U.K., Laboratory of Molecular Biophysics and Department of Biochemistry, University of Oxford, Oxford, OX1 3QU U.K., and Developmental Therapeutics Program, National Cancer Institute, Bethesda, Maryland 20892-7458 From the University of Newcastle, Newcastle upon Tyne; City Hospital, National Health Services Trust, Birmingham; The Royal Marsden Hospital, Sutton Surrey; Weston Park Hospital, Cancer Research Centre, Sheffield; Christie Hospital National Health Services Trust, Manchester, United Kingdom; Queen Elizabeth II Health Sciences Centre, Victoria Site, Halifax, Nova Scotia; BC Cancer Agency, Vancouver; BC Cancer Agency, Kelowna, British Columbia; Saskatoon Cancer Centre, Saskatoon, Saskatoon; McGill... Newcastle Cancer Centre, Northern Institute for Cancer Research, Paul O’Gorman Building, Medical School, Framlington Place, Newcastle upon Tyne NE2 4HH, U.K. Authors' Affiliations: Newcastle General Hospital, New Castle, United Kingdom Pfizer Global R&DLa Jolla Laboratories, 10770 Science Center Drive, San Diego, California 92121, Anadys Pharmaceuticals, 3115 Merryfield Row, San Diego, California 92121, Quorex Pharmaceuticals, 1890 Rutherford Road, #200, Carlsbad, California 92008, and University of Newcastle, Newcastle upon Tyne NE2 4HH, United Kingdom Northern Institute for Cancer Research, School of Natural SciencesChemistry, Bedson Building, University of Newcastle upon Tyne, Newcastle upon Tyne NE1 7RU, U.K., and Northern Institute for Cancer Research, Paul O'Gorman Building, Medical School, University of Newcastle upon Tyne, Framlington Place, Newcastle upon Tyne NE2 4HH, U.K. Department of Chemistry, Bedson Building, The University, Newcastle upon Tyne NE1 7RU, U.K.; Cancer Research Unit, Medical School, Framlington Place, Newcastle upon Tyne NE2 4HH, U.K.; AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K.; and Departments of Cellular and Molecular Physiology and Pharmacology, Pennsylvania State University College of Medicine, The Milton S. Hershey Medical Center, P.O. Box 850, Hershey, Pennsylvania 17033 1Northern Institute for Cancer Research, Medical School, University of Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom and Head and Neck Unit Royal Marsden Hospital London England Department of Chemistry, Bedson Building, The University, Newcastle upon Tyne NE1 7RU, U.K., and Cancer Research Unit, Medical School, Framlington Place, Newcastle upon Tyne NE2 4HH, U.K. Department of Chemistry, Bedson Building, The University, Newcastle upon Tyne NE1 7RU, U.K.; Cancer Research Unit, Medical School, Framlington Place, Newcastle upon Tyne NE2 4HH, U.K.; and Agouron Pharmaceuticals Inc., San Diego, California 92121 Pfizer Global Research and Development, La Jolla/Agouron Pharmaceuticals, Inc., 10770 Science Center Drive, San Diego, California 92121, and University of Newcastle, Newcastle upon Tyne, NE2 4HH, U.K. 1Northern Institute for Cancer Research, University of Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom; 1Northern Institute for Cancer Research, University of Newcastle;; 2Northern Centre for Cancer Treatment, Newcastle upon Tyne, United Kingdom; |
Incoming Links
Showing number of triples: 1 to 74 of 74.